Figure 6
Inhibition of migration and adhesion by Me6. (A-B) Me6 inhibited the migration of mouse BM MNCs and human Jurkat cells toward SDF-1α in a dose-dependent manner. n = 6. *P < .05 and **P < .01 vs the SDF-1α group. (C-F) Me6 significantly inhibited the adhesion of BM MNCs and human Jurkat cells to fibronectin and VCAM-1 in a dose-dependent manner. n = 6. *P < .05 and **P < .01 vs the control group. (G-H) Me6 inhibited the migration of human cord blood (CB) MNCs and CD34+ HSCs toward SDF-1α in a dose-dependent manner. n = 6. *P < .05 and **P < .01 vs the SDF-1α group. (I-J) Me6 significantly inhibited the adhesion of human cord blood MNCs and CD34+ HSCs to fibronectin in a dose-dependent manner. n = 6. *P < .05 and **P < .01 vs the control group.

Inhibition of migration and adhesion by Me6. (A-B) Me6 inhibited the migration of mouse BM MNCs and human Jurkat cells toward SDF-1α in a dose-dependent manner. n = 6. *P < .05 and **P < .01 vs the SDF-1α group. (C-F) Me6 significantly inhibited the adhesion of BM MNCs and human Jurkat cells to fibronectin and VCAM-1 in a dose-dependent manner. n = 6. *P < .05 and **P < .01 vs the control group. (G-H) Me6 inhibited the migration of human cord blood (CB) MNCs and CD34+ HSCs toward SDF-1α in a dose-dependent manner. n = 6. *P < .05 and **P < .01 vs the SDF-1α group. (I-J) Me6 significantly inhibited the adhesion of human cord blood MNCs and CD34+ HSCs to fibronectin in a dose-dependent manner. n = 6. *P < .05 and **P < .01 vs the control group.

Close Modal

or Create an Account

Close Modal
Close Modal